Please login to the form below

Not currently logged in
Email:
Password:

Allegro

This page shows the latest Allegro news and features for those working in and with pharma, biotech and healthcare.

Ashfield wins gold at the UK Employee Experience Awards

Ashfield wins gold at the UK Employee Experience Awards

Fast-track for medical writers impresses judges. Ashfield Healthcare Communications has won gold for its medical writing training programme allegro at the UK Employee Experience Awards 2019. ... The allegro team attended the awards last week and took

Latest news

  • GCI Health expands into Asia, Lucid adds to Futures Academy and more GCI Health expands into Asia, Lucid adds to Futures Academy and more

    Ashfield’s medical writers graduate. Ashfield Healthcare Communications has seen its first cohort of medical writers graduate from training programme Allegro. ... The company plans to increase recruitment to Allegro this year, expanding the geographic

  • ROAD wins new account, Ark rebrands and Ashfield sees third intake of writers ROAD wins new account, Ark rebrands and Ashfield sees third intake of writers

    Ashfield’s Allegro welcomes third intake of medical writers. Following on the from the success of the first two intakes, 15 more employees joined the business as associate medical writers, and ... The Allegro programme has been designed to ensure

  • Ashfield welcomes second intake of medical writers Ashfield welcomes second intake of medical writers

    Neil Marmont, Allegro’s programme director, said: “The 15 associate medical writers who joined Allegro in January have all successful completed the eight-week training curriculum and are now delivering work ... Ashfield aims to train up to 80 writers

  • Multiplying options for MS

    Gilenya. In December 2010, top-line results from the pivotal phase III ALLEGRO trial were announced, indicating that the drug met its primary endpoint of reducing annualised relapse rates in patients ... Completion of this trial is expected later in 2011.

  • MS treatment hopes

    or placebo, and the similar, two-armed (laquinimod versus placebo) ALLEGRO trial.

More from news
Approximately 1 fully matching, plus 7 partially matching documents found.

Latest from PMHub

  • Allegro welcomes third intake of aspiring medical writers to fast-track training programme

    Ashfield Healthcare Communications, a leading global healthcare communications agency, today welcomes its third intake of aspiring medical writers into its accelerated medical writing training programme, Allegro. ... The Allegro programme has been

  • Ashfield

    Allegro welcomes third intake of aspiring medical writers to fast-track training programme. ... Ashfield Healthcare Communications, a leading global healthcare communications agency, today welcomes its third intake of aspiring medical writers into its

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Jet Off with Maloff Protect

Latest intelligence

The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
How is the NHS Long-term Plan being put into action?
Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...
real world studies
The evolution of real-world studies
How industry and regulators are using real-world data...

Infographics